Kala Bio Total Liabilities (Quarterly) Analysis

Kala Bio Inc (KALA)

6.75 -0.03 (-0.43%) USD | NASDAQ | Nov 05, 16:00

6.75 0.00 (0.00%) After-Hours: 16:18

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
June 30, 2024	47.89M
March 31, 2024	46.37M
December 31, 2023	48.44M
September 30, 2023	49.90M
June 30, 2023	49.01M
March 31, 2023	48.76M
December 31, 2022	67.85M
September 30, 2022	86.67M
June 30, 2022	116.53M
March 31, 2022	116.86M
December 31, 2021	122.62M
September 30, 2021	132.34M
June 30, 2021	131.19M
March 31, 2021	120.04M
December 31, 2020	121.61M
September 30, 2020	119.07M

Date	Value
June 30, 2020	116.57M
March 31, 2020	117.02M
December 31, 2019	124.63M
September 30, 2019	117.96M
June 30, 2019	117.75M
March 31, 2019	114.65M
December 31, 2018	115.99M
September 30, 2018	29.14M
June 30, 2018	27.50M
March 31, 2018	24.72M
December 31, 2017	26.87M
September 30, 2017	24.83M
June 30, 2017	136.01M
March 31, 2017	15.14M
December 31, 2016	134.09M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

46.37M

Minimum

Mar 2024

132.34M

Maximum

Sep 2021

93.86M

Average

116.57M

Median

Jun 2020

Total Liabilities (Quarterly) Benchmarks

CEL-SCI Corp	15.60M
AIM ImmunoTech Inc	9.613M
IGC Pharma Inc	2.714M
NovaBay Pharmaceuticals Inc	4.542M
Protalix BioTherapeutics Inc	62.96M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly)	61.61M
Shareholders Equity (Quarterly)	13.72M